The Confidence Conundrum
Are we under-serving patients by avoiding conversations about confidence?
And in the same vein, are we short-changing HCPs by steering clear of it too?
A Cautious Observation: Many dermatology brands portray confidence. Very few address it directly.
Which is ironic. Skin is our most visible organ. It’s read instantly. It shapes first impressions whether we acknowledge it or not. And research has shown what most patients already know instinctively: when visible skin conditions are present, perception shifts. Expectations for intelligence, success and confidence are all subtly downgraded.
The emotional stakes are real. Yet confidence rarely becomes the headline.
In the past, we worked with a brand that explored this very gap in research. The findings were striking. But while the data informed earned media and creative subtext, it never became the central message. It hovered just beneath the surface.
Why?
Some would point to regulatory boundaries. Others to research frameworks built around more “functional” barriers. I’ve also heard a familiar hesitation:
Is this emotional overreach?
Does it feel inauthentic?
Will it make us uncomfortable internally?
Those are valid concerns.
And still there are moments when leaning in has worked.
An acne awareness campaign that visualized the internal monologue patients carry. A tracker tool that paired selfies with emotional check-ins to open deeper patient compliance and provider dialogue.
In both cases, the psycho-social dimension resonated. Engagement deepened. Conversations shifted. But even then, confidence wasn’t the brand’s lead claim. It remained adjacent.
That pattern feels worth examining.
Because while we spend our days in claim matrices and benefit ladders, the lived experience of dermatology is rarely just clinical. Patients don’t ask for clearer skin in isolation. They ask for relief from what that condition is costing them socially, professionally, emotionally.
So where should emotional storytelling begin?
And where should it stop?
Who decides what’s appropriate to communicate? Is it brand teams? Compliance? Providers? Patients?
Compliance is non-negotiable. Fair balance matters. But is there more room than we assume? What would happen if medical, legal, and commercial teams collaborated earlier — at the genesis of message development — to responsibly explore the confidence dimension rather than shying away from it?
Perhaps the Bigger Question is This: Are we avoiding confidence because it’s risky, or because it’s uncomfortable?
The root may run deeper than category convention.
A decade in dermatology has taught us that expertise isn’t static. So we aren’t either. The questions evolve. The guardrails shift. The human realities remain.
This is the first in a series of open conversations about the tensions shaping our industry. We’ll look at launch pressure versus longevity, simplification versus credibility, efficiency versus humanity.
We don’t have final answers.
But we believe the conversation is overdue.
What’s your take?
